241 results
Page 9 of 13
8-K
EX-99.3
g9g7r76f
23 Apr 12
BioTime Provides Update on ReneviaTM Product Development
12:00am
8-K
EX-99.1
5gfyb9 ra
14 Mar 12
BioTime Announces Fourth Quarter and Fiscal Year End 2011 Financial Results and Recent Corporate Accomplishments
12:00am
8-K
faqzq5 c3
16 Dec 11
BioTime’s Subsidiary OncoCyte Corporation Announces Plans for the Novel Pan-Cancer Diagnostic Product PanC-DxTM
12:00am
8-K
EX-99.1
4fg06 x5fmeekf
16 Dec 11
BioTime’s Subsidiary OncoCyte Corporation Announces Plans for the Novel Pan-Cancer Diagnostic Product PanC-DxTM
12:00am
8-K
9zto266dxkd
12 Dec 11
BioTime Successfully Completes HyStem®-Rx Preclinical ISO 10993 Studies
12:00am
8-K
EX-99.1
14c61hdnafv 7dpnanm
12 Dec 11
BioTime Successfully Completes HyStem®-Rx Preclinical ISO 10993 Studies
12:00am
DEFA14A
otapn9e2
24 May 11
Additional proxy soliciting materials
12:00am
8-K
EX-99.1
r1sg1qmzv2uusn3lg7d7
3 May 11
BioTime Initiates Clinical Development Program for HyStem®-Rx as a Cell Delivery Device for Reconstructive Surgery and Other Cell-Based Therapies
12:00am
8-K
EX-99.1
51goigefykb2
22 Mar 11
BioTime Announces the Closing of the Merger of Glycosan BioSystems with OrthoCyte Corporation
12:00am
8-K
4qzht5kx
22 Mar 11
BioTime Announces the Closing of the Merger of Glycosan BioSystems with OrthoCyte Corporation
12:00am